Latent inhibition of rotation chair-induced nausea in healthy male and female volunteers

Psychosomatic Medicine

Volumn 67, Issue 2, 2005, Pages 335-340

  Klosterhalfen, Sibylle ^a   Kellermann, Sandra ^a   Stockhorst, Ursula ^a   Wolf, Jutta ^b   Kirschbaum, Clemens ^b   Hall, Geoffrey ^c   Enck, Paul ^d  

^a University of Ðüsseldorf   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Gender; Latent inhibition; Motion sickness; Nausea; Pavlovian conditioning

Indexed keywords

HYDROCORTISONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTICIPATION; ARTICLE; CHAIR; CONDITIONED REFLEX; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENDER; HABITUATION; HUMAN; HUMAN EXPERIMENT; LATENT INHIBITION; LEARNING; MALE; MOTION SICKNESS; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; ROTATION; SALIVA LEVEL; STRESS; SYMPTOM; VOLUNTEER;

ADULT; ANTINEOPLASTIC AGENTS; CONDITIONING, CLASSICAL; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; HYDROCORTISONE; MALE; MOTION SICKNESS; NAUSEA; POSTURE; ROTATION; SEX FACTORS; TREATMENT OUTCOME; VOMITING, ANTICIPATORY;

EID: 15744378075     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000156930.00201.e0     Document Type: Article

References (43)

1. Andrews PLR, Rapeport WG, Sanger GJ. Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci 1988;9:334-41.
2. Stockhorst U, Klosterhalfen S, Steingrüber HJ. Conditioned nausea and further side-effects in cancer chemotherapy: a review. J Psychophysiol 1998;12(suppl 1):14-35.
3. Boakes RA, Tarrie N, Barnes BW, Tattersall MHN. Prevalence of anticipatory nausea and other side-effects in cancer patients receiving cancer chemotherapy. Eur J Cancer 1993;29:866-70.
4. Carey MP, Burish TG. Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychol Bull 1988;104:307-25.
5. Hall G. Context aversion, Pavlovian conditioning, and the psychological side effects of chemotherapy. Eur Psychol 1997;2:118-24.
6. Nesse RM, Carli T, Curtis GC, Kleinman PD. Pretreatment nausea in cancer chemotherapy: a conditioned response? Psychosom Med 1980;42:33-6.
7. Stockhorst U, Spennes-Saleh S, Körholz D, Göbel U, Schneider ME, Steingrüber HJ, Klosterhalfen S. Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy. Brain Behav Immun 2000;14:198-218.
8. Rodriguez M, Lopez M, Symonds M, Hall G. Lithium-induced context aversion in rats as a model of anticipatory nausea in humans. Physiol Behav 2000;71:571-9.
9. Symonds M, Hall G. Contextual conditioning with an illness US is attenuated by the antiemetic ondansetron. Psychobiology 2000;28:360-6.
10. Stockhorst U, Wiener JA, Klosterhalfen S, Klosterhalfen W, Aul C, Steingrüber HJ. Effects of overshadowing on conditioned nausea in cancer patients. Physiol Behav 1998;64:743-53.
11. Lubow RE. Latent inhibition and conditioned attention theory. Cambridge: Cambridge University Press; 1989.
12. Lubow RE, Gewirtz JC. Latent inhibition in humans: data, theory, and implications for schizophrenia. Psychol Bull 1995;117:87-103.
13. Fanselow MS. Factors governing one-trial contextual conditioning. Animal Learn Behav 1990;18:246-70.
14. Kiernan MJ, Westbrook RF. Effects of exposure to a to-be-shocked environment upon the rat's freezing response: evidence for facilitation, latent inhibition, and perceptual learning. Q J Exp Psychol 1993;46B:271-88.
15. Bennett CH, Tremain M, Mackintosh NJ. Facilitation and retardation of flavour aversion conditioning following prior exposure to the CS. Q J Exp Psychol 1996;49B:220-30.
16. Klosterhalfen S, Rüttgers A, Krumrey E, Otto B, Stockhorst U, Riepl RL, Probst T, Enck P. Pavlovian conditioning of taste aversion using a motion sickness paradigm. Psychosom Med 2000;62:671-7.
17. Klosterhalfen S, Kuhlbusch R, Kugler J, Reichardt B, Riepl RL, Loose R, Probst T, Enck P. Rotating-chair induced motion sickness and anticipatory nausea. In: Brähler E, Schumacher J, editors. Psychologie und Soziologie in der Medizin. Giessen: Psychosozial Verlag; 1996:93.
18. Reichardt B, Riepl RL, Lehnert P, Enck P. Endocrine indicators of nausea and vomiting in motion sickness. J Psychophysiol 1998;12(suppl 1):50-5.
19. Fredrikson M, Hursti T, Furst CJ, Steineck G, Borjeson S, Wikblom M, Peterson C. Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br J Cancer 1992;65:779-80.
20. Kim MS, Chey WD, Owyang C, Hasler WL. Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness. Am J Physiol 1997;272:G853-62.
21. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, Shaheen NJ, Sandler RS. Digestive and liver diseases statistics, 2004. Gastroenterology 2004;126:1448-53.
22. Panayi GS, Corrigall VM, Henderson B. Stress cytokines: pivotal proteins in immune regulatory networks. Curr Opin Immunol 2004;16:531-4.
23. Jokerst MD, Gatto M, Fazio R, Gianaros PJ, Stern RM, Koch KL. Effects of gender of subjects and experimenter on susceptibility to motion sickness. Aviat Space Environ Med 1999;70:962-5.
24. Cheung B, Hofer K. Lack of gender difference in motion sickness induced by vestibular Coriolis cross-coupling. J Vestib Res 2002;12:191-200.
25. Park AH, Hu S. Gender differences in motion sickness history and susceptibility to optokinetic rotation-induced motion sickness. Aviat Space Environ Med 1999;70:1077-80.
26. Liaw CC, Chang HK, Liau CT, Huang JS, Lin YC, Chen JS. Reduced maintenance of complete protection from emesis for women during chemotherapy cycles. Am J Clin Oncol 2003;26:12-5.
27. Liaw CC, Wang CH, Chang HK, Liau CT, Yeh KY, Huang JS, Lin YC. Gender discrepancy observed between chemotherapy-induced emesis and hiccups. Support Care Cancer 2001;9:435-41.
28. Friedman CJ, Burns HA 3rd, Yocom K, Blackburn LM, Gruben D. Oral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy. Oncologist 2000;5:136-43.
29. Golding JF. Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness. Brain Res Bull 1998;47:507-16.
30. Hursti TJ, Fredrikson M, Steineck G, Borjeson S, Furst CJ, Peterson C. Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids. Br J Cancer 1993;68:112-4.
31. Kirschbaum C, Prussner JC, Stone AA, Federenko I, Gaab J, Lintz D, Schommer N, Hellhammer DH. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom Med 1995;57:468-74.
32. Peterson C, Hursti TJ, Borjeson S, Avall-Lundqvist E, Fredrikson M, Furst CJ, Lomberg H, Steineck G. Single high-dose dexamethasone improves the effect of ondansetron on acute chemotherapy-induced nausea and vomiting but impairs the control of delayed symptoms. Support Care Cancer 1996;4:440-6.
33. Bartolomucci A, Palanza P, Parmigiani S, Pederzani T, Merlot E, Neveu PJ, Dantzer R. Chronic psychosocial stress down-regulates central cytokines mRNA. Brain Res Bull 2003;62:173-8.
34. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001;933:222-34.
35. Tyc VL, Mulhern RK, Bieberich AA. Anticipatory nausea and vomiting in pediatric cancer patients: an analysis of conditioning and coping variables. J Dev Behav Pediatr 1997;18:27-33.
36. Weddington WW, Miller NJ, Sweet DL. Anticipatory nausea and vomiting associated with cancer chemotherapy. J Psychosom Res 1984;28:73-7.
37. Fetting JH, Wilcox PM, Iwata BA, Criswell EL, Bosmajian LS, Sheidler VR. Anticipatory nausea and vomiting in an ambulatory medical oncology population. Cancer Treat Rep 1983;67:1093-8.
38. Boakes RA, Tarrier N, Barnes BW, Tattersall MH. Prevalence of anticipatory nausea and other side-effects in cancer patients receiving chemotherapy. Eur J Cancer 1993;29A:866-70.
39. Hoffmann H, Janssen E, Turner SL. Classical conditioning of sexual arousal in women and men: effects of varying awareness and biological relevance of the conditioned stimulus. Arch Sex Behav 2004;33:43-53.
40. Staud R, Robinson ME, Vierck CJ Jr, Price DD. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003;101:167-74.
41. Guimaraes FS, Hellewell J, Hensman R, Wang M, Deakin JF. Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: influence of gender, instruction, personality and placebo. Psychopharmacology (Berl) 1991;104:231-6.
42. Hetrick WP, Sandman CA, Bunney WE Jr., Jin Y, Potkin SG, White MH. Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry 1996;39:51-8.
43. Rostami-Hodjegan A, Abdul-Manap R, Wright CE, Tucker GT, Morice AH. The placebo response to citric acid-induced cough: pharmacodynamics and gender differences. Pulm Pharmacol Ther 2001;14:315-9.